Contributing to better vaccine information across Europe
Surrey academics join continent-wide coalition of organisations to revolutionise benefit/risk assessment of vaccines.
Experts from the University of Surrey are among those to contribute to the newly-launched ADVANCE project, a pioneering €10 million pan-European alliance that will provide evidence on the benefits and risks of vaccines more rapidly.
ADVANCE will gather the rich information generated in clinical routine care and captured in health care databases and disease registries to cultivate a more comprehensive understanding of the data captured across the continent. This is vital to benefit/risk evaluations by health care providers, vaccine manufacturers, and public health and regulatory bodies, as well as maintaining public confidence in safe and effective vaccines that prevent devastating diseases.
Surrey’s contribution to the project comes through its Clinical Informatics and Health Outcomes Research Group. Led by Professors Simon de Lusignan and Simon Jones of the Department of Health Care Management and Policy, the Group will identify health databases capable of delivering accelerated research about vaccine benefits and risks.
As part of the project, the University of Surrey team will develop models to facilitate the integration of different data sources to make better use of existing health data and bring vaccines into mainstream practice. In addition, the Group we will develop guidance to help support the approval of vaccine research.
The project, which was launched in Brussels on 26 November, is revolutionary in the way it brings together representatives of all stakeholders. Supported by the Innovative Medicines Initiative (IMI), it brings together 27 partners – including public health and regulatory bodies at European and national level, vaccine manufacturers, universities, and small and medium-sized enterprises.
ADVANCE is in a unique position to help maintain public confidence in vaccines that protect populations from devastating diseases across Europe.
Immunisation through vaccines prevents between two and three million deaths worldwide each year from diseases such as diphtheria, tetanus, pertussis (whooping cough) and measles.